EEP Stock Overview
Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Euroespes, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.34 |
| 52 Week High | €0.49 |
| 52 Week Low | €0.32 |
| Beta | 0.030 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -29.17% |
| 3 Year Change | -30.61% |
| 5 Year Change | -56.13% |
| Change since IPO | -88.36% |
Recent News & Updates
Shareholder Returns
| EEP | ES Life Sciences | ES Market | |
|---|---|---|---|
| 7D | 0% | 1.4% | 0.5% |
| 1Y | -29.2% | -4.5% | 11.6% |
Return vs Industry: EEP underperformed the Spanish Life Sciences industry which returned -16.7% over the past year.
Return vs Market: EEP underperformed the Spanish Market which returned 7.5% over the past year.
Price Volatility
| EEP volatility | |
|---|---|
| EEP Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 6.9% |
| Market Average Movement | 3.2% |
| 10% most volatile stocks in ES Market | 5.8% |
| 10% least volatile stocks in ES Market | 0.6% |
Stable Share Price: EEP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EEP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 39 | Ramon Cacabelos Garcia | www.euroespes.com |
Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, digital diagnostics, radiodiagnosis, clinical analysis laboratory, nursing, and cardiology.
Euroespes, S.A. Fundamentals Summary
| EEP fundamental statistics | |
|---|---|
| Market cap | €3.67m |
| Earnings (TTM) | -€1.14m |
| Revenue (TTM) | €3.86m |
1.0x
P/S Ratio-3.2x
P/E RatioIs EEP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EEP income statement (TTM) | |
|---|---|
| Revenue | €3.86m |
| Cost of Revenue | €2.47m |
| Gross Profit | €1.38m |
| Other Expenses | €2.52m |
| Earnings | -€1.14m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 35.92% |
| Net Profit Margin | -29.49% |
| Debt/Equity Ratio | 68.3% |
How did EEP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/28 12:01 |
| End of Day Share Price | 2023/12/01 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Euroespes, S.A. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|